We are pleased to announce that the tasks planned as a part of the projects proceed without any obstacles and we consistently achieve the assumed goals:

• Nanobiome project – results for the first part of the volunteers were published. The remaining reports will be released in the coming weeks.

• SARS-CoV-2 genome sequencing project – we successively analyze the samples. Over 99% of them has been identified as the so-called British variant.

• Our company won two tenders in the area of nanopore sequencing. We’ll be sharing details next week.

• The Molecular Diagnostics Laboratory accomplished its goals set for April.